Placebo News and Research

RSS

Electrical stimulation boosts math skills in people with weaker neural links

The strength of certain neural connections can predict how well someone can learn math, and mild electrically stimulating these networks can boost learning, according to a study published on July 1st in the open-access journal PLOS Biology by Roi Cohen Kadosh from University of Surrey, United Kingdom, and colleagues.

2 Jul 2025

Plant-based fitness supplements for reversing metabolic syndrome

Research indicates that specific plant-based supplements, combined with exercise, can improve cardiometabolic markers in those at risk for metabolic syndrome.

2 Jul 2025

Clinical trial examines whether Ambroxol can slow dementia in people with Parkinson's

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression.

1 Jul 2025

Common autoimmune drug shown to help patients with giant cell arteritis

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University of Pennsylvania published in the New England Journal of Medicine.

25 Jun 2025

Tirzepatide rewires appetite and slashes calorie intake in new obesity trial

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with overweight or obesity, outperforming liraglutide and placebo. Brain imaging revealed that tirzepatide also lowered neural responses to high-fat, high-sugar food cues, offering mechanistic insight into its potent weight-loss effects.

25 Jun 2025

Do omega-3 supplements boost athletic performance?

Combining omega-3 supplementation with resistance training significantly improved lipid profiles, inflammation markers, antioxidant capacity, and neuromuscular performance in healthy men. While group × time effects weren’t significant, within-group gains suggest real physiological benefits.

25 Jun 2025

Is aspartame safe for blood sugar? Study answers the big question

A major systematic review and meta-analysis found that aspartame has little to no effect on blood glucose, insulin, or appetite-regulating hormones in humans. Evidence certainty is very low, with no significant long-term metabolic impact identified.

25 Jun 2025

Once-monthly obesity injection shows double-digit weight loss in major clinical trial

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with or without diabetes, in a phase 2 randomized trial. The drug demonstrated an acceptable safety profile and supports further study in phase 3 trials.

24 Jun 2025

Clinical trial finds new benefits of semaglutide for adults with type 1 diabetes

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with Type 1 diabetes who use automated insulin delivery systems.

23 Jun 2025

Cagrilintide and semaglutide together drive record weight loss in global trial

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful weight loss in adults with obesity but no diabetes. The combination outperformed either drug alone and improved multiple cardiometabolic health markers.

23 Jun 2025

Amycretin delivers unprecedented weight loss in early trial for obesity treatment

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and sustained weight loss in adults with overweight or obesity during a phase 1b/2a trial. The treatment was generally well tolerated, with mostly mild to moderate gastrointestinal side effects, supporting further investigation in larger, longer studies.

23 Jun 2025

Cannabidiol may help reduce problematic behaviors in autistic boys

Researchers at the Center for Medicinal Cannabis Research at University of California San Diego School of Medicine have found that cannabidiol (CBD), a non-intoxicating compound found in cannabis, could help reduce problematic behaviors in autistic boys.

23 Jun 2025

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research.

17 Jun 2025

Single-dose of psilocybin shows long-term relief for depression in cancer patients

New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in mushrooms-can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder.

16 Jun 2025

Placebo News and Research

Electrical stimulation boosts math skills in people with weaker neural links

Plant-based fitness supplements for reversing metabolic syndrome

Clinical trial examines whether Ambroxol can slow dementia in people with Parkinson's

Common autoimmune drug shown to help patients with giant cell arteritis

Tirzepatide rewires appetite and slashes calorie intake in new obesity trial

Do omega-3 supplements boost athletic performance?

Is aspartame safe for blood sugar? Study answers the big question

Once-monthly obesity injection shows double-digit weight loss in major clinical trial

Clinical trial finds new benefits of semaglutide for adults with type 1 diabetes

Cagrilintide and semaglutide together drive record weight loss in global trial

Amycretin delivers unprecedented weight loss in early trial for obesity treatment

Cannabidiol may help reduce problematic behaviors in autistic boys

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Single-dose of psilocybin shows long-term relief for depression in cancer patients

Two existing medications work effectively together in treating alcohol use disorder

Empagliflozin preserves kidney function in heart attack patients

Low-dose vitamin D supplements can increase effectiveness of chemotherapy in breast cancer patients

Weight loss drug semaglutide proven safe and effective for people with schizophrenia

Using causal machine learning to identify potential ALS treatments

Creatine offers broad health benefits beyond fitness

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News